Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

CDC like kinase 1

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 1990

Nomenclature: CDC like kinase 1

Abbreviated Name: CLK1

Family: CLK family

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 484 2q33.1 CLK1 CDC like kinase 1
Mouse - 483 1 29.09 cM Clk1 CDC-like kinase 1
Rat - 483 9 q31 Clk1 CDC-like kinase 1
Previous and Unofficial Names Click here for help
dual specificity protein kinase CLK1 | STY
Database Links Click here for help
Alphafold P49759 (Hs), P22518 (Mm)
BRENDA 2.7.12.1
ChEMBL Target CHEMBL4224 (Hs), CHEMBL1075280 (Mm)
Ensembl Gene ENSG00000013441 (Hs), ENSMUSG00000026034 (Mm), ENSRNOG00000025768 (Rn)
Entrez Gene 1195 (Hs), 12747 (Mm), 301434 (Rn)
Human Protein Atlas ENSG00000013441 (Hs)
KEGG Enzyme 2.7.12.1
KEGG Gene hsa:1195 (Hs), mmu:12747 (Mm), rno:301434 (Rn)
OMIM 601951 (Hs)
Pharos P49759 (Hs)
RefSeq Nucleotide NM_001162407 (Hs), NM_001042634 (Mm), NM_001106913 (Rn)
RefSeq Protein NP_001155879 (Hs), NP_001036099 (Mm), NP_001100383 (Rn)
SynPHARM 81086 (in complex with KH-CB19)
UniProtKB P49759 (Hs), P22518 (Mm)
Wikipedia CLK1 (Hs)
Selected 3D Structures Click here for help
Image of receptor 3D structure from RCSB PDB
Description:  Crystal structure of human CLK1 in complex with 10Z-Hymenialdisine
PDB Id:  1Z57
Resolution:  1.7Å
Species:  Human
References:  2
Enzyme Reaction Click here for help
EC Number: 2.7.12.1

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
Cdc2-like kinase inhibitor Small molecule or natural product Primary target of this compound Click here for species-specific activity table Ligand has a PDB structure Mm Inhibition 8.0 pKi 9
⤷ pKi 8.0 (Ki 1x10-8 M) [9]
leucettine L41 Small molecule or natural product Click here for species-specific activity table Mm Inhibition 10.8 pIC50 7
⤷ pIC50 10.8 (IC50 1.5x10-11 M) [7]
compound 17 [PMID: 23642479] Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 8.7 pIC50 5
⤷ pIC50 8.7 (IC50 2x10-9 M) [5]
KH-CB19 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Ligand has a PDB structure Hs Inhibition 7.7 pIC50 8
⤷ pIC50 7.7 (IC50 1.97x10-8 M) [8]
Cdc2-like kinase inhibitor Small molecule or natural product Primary target of this compound Click here for species-specific activity table Ligand has a PDB structure Mm Inhibition 7.7 pIC50 9
⤷ pIC50 7.7 (IC50 2x10-8 M) [9]
compound 3b [PMID: 23454515] Small molecule or natural product Click here for species-specific activity table Mm Inhibition 7.2 pIC50 3
⤷ pIC50 7.2 (IC50 6.1x10-8 M) [3]
ML315 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 7.2 pIC50 5
⤷ pIC50 7.2 (IC50 6.8x10-8 M) [5]
compound 2 [PMID: 22560567] Small molecule or natural product Click here for species-specific activity table Hs Inhibition 6.7 pIC50 4
⤷ pIC50 6.7 (IC50 2.1x10-7 M) [4]
MW01 Small molecule or natural product Click here for species-specific activity table Hs Inhibition 6.6 pIC50 10
⤷ pIC50 6.6 (IC50 2.5x10-7 M) [10]
MW05 Small molecule or natural product Click here for species-specific activity table Hs Inhibition 5.7 pIC50 10
⤷ pIC50 5.7 (IC50 2.23x10-6 M) [10]
View species-specific inhibitor tables
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 6,11
Key to terms and symbols Click column headers to sort
Target used in screen: CLK1
Ligand Sp. Type Action Value Parameter
A-674563 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 8.9 pKd
lestaurtinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 8.0 pKd
NVP-TAE684 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.9 pKd
GSK-1838705A Small molecule or natural product Hs Inhibitor Inhibition 7.7 pKd
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 7.7 pKd
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.5 pKd
KW-2449 Small molecule or natural product Hs Inhibitor Inhibition 7.2 pKd
R547 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.2 pKd
AST-487 Small molecule or natural product Hs Inhibitor Inhibition 7.0 pKd
TG-100-115 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.8 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen Click here for help
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

http://www.millipore.com/techpublications/tech1/pf3036
http://www.reactionbiology.com/webapps/main/pages/kinase.aspx

Reference: ...1
Key to terms and symbols Click column headers to sort
Target used in screen: nd/CLK1
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
K-252a Small molecule or natural product Hs Inhibitor Inhibition 1.4
Cdk1/2 inhibitor III Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 2.3
JAK3 inhibitor VI Small molecule or natural product Hs Inhibitor Inhibition 4.1
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 11.9
PKR inhibitor Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 19.9
dorsomorphin Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 20.0
sunitinib Small molecule or natural product Approved drug Ligand has a PDB structure Hs Inhibitor Inhibition 23.3
SU11652 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 34.2
indirubin derivative E804 Small molecule or natural product Hs Inhibitor Inhibition 36.6
Cdc2-like kinase inhibitor Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 41.8
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]

2. Bullock AN, Das S, Debreczeni JE, Rellos P, Fedorov O, Niesen FH, Guo K, Papagrigoriou E, Amos AL, Cho S et al.. (2009) Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation. Structure, 17 (3): 352-62. [PMID:19278650]

3. Burgy G, Tahtouh T, Durieu E, Foll-Josselin B, Limanton E, Meijer L, Carreaux F, Bazureau JP. (2013) Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines. Eur J Med Chem, 62: 728-37. [PMID:23454515]

4. Coffman K, Brodney M, Cook J, Lanyon L, Pandit J, Sakya S, Schachter J, Tseng-Lovering E, Wessel M. (2011) 6-amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3β inhibitors. Bioorg Med Chem Lett, 21 (5): 1429-33. [PMID:21295469]

5. Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J. (2013) Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett, 23 (12): 3654-61. [PMID:23642479]

6. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

7. Debdab M, Carreaux F, Renault S, Soundararajan M, Fedorov O, Filippakopoulos P, Lozach O, Babault L, Tahtouh T, Baratte B et al.. (2011) Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing. J Med Chem, 54 (12): 4172-86. [PMID:21615147]

8. Fedorov O, Huber K, Eisenreich A, Filippakopoulos P, King O, Bullock AN, Szklarczyk D, Jensen LJ, Fabbro D, Trappe J et al.. (2011) Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing. Chem Biol, 18 (1): 67-76. [PMID:21276940]

9. Fedorov O, Marsden B, Pogacic V, Rellos P, Müller S, Bullock AN, Schwaller J, Sundström M, Knapp S. (2007) A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proc Natl Acad Sci USA, 104 (51): 20523-8. [PMID:18077363]

10. Mucka P, Lindemann P, Bosco B, Willenbrock M, Radetzki S, Neuenschwander M, Brischetto C, Peter von Kries J, Nazaré M, Scheidereit C. (2023) CLK2 and CLK4 are regulators of DNA damage-induced NF-κB targeted by novel small molecule inhibitors. Cell Chem Biol, 30 (10): 1303-1312.e3. [PMID:37506701]

11. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

CLK family: CDC like kinase 1. Last modified on 25/10/2023. Accessed on 15/07/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1990.